Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 16,416.18 -8.67 -0.05%
S&P 500 1,863.64 1.33 0.07%
NASDAQ 4,095.10 8.88 0.22%
Ticker Volume Price Price Delta
STOXX 50 3,155.81 16.55 0.53%
FTSE 100 6,625.25 41.08 0.62%
DAX 9,409.71 91.89 0.99%
Ticker Volume Price Price Delta
NIKKEI 14,417.53 -0.15 -0.00%
TOPIX 1,166.59 0.04 0.00%
HANG SENG 22,760.24 64.23 0.28%

Geron Corp. : Geron Announces Conference Call to Discuss Fourth Quarter and Annual 2012 Financial Results

 Geron Corp. : Geron Announces Conference Call to Discuss Fourth Quarter and
                        Annual 2012 Financial Results

Menlo Park, Calif., March 5, 2013 - Geron Corporation (Nasdaq: GERN) will
announce its financial results for the fourth quarter and year ended December
31, 2012, on Tuesday, March 12, 2013, after the market close. Geron's
management will host a conference call for analysts and investors on
Wednesday, March 13, 2013, at 9:00 a.m. Eastern Time to discuss the company's
fourth quarter and annual results and highlights.

Participants can access the conference call live via telephone by dialing
866-270-6057 (U.S.); 617-213-8891 (international). The passcode is 80790305.
If accessing the conference call by telephone, please dial in at least 10
minutes early to minimize any delay in joining the call. A live audio-only
webcast is also available at
The audio webcast of the conference call will be available for replay
approximately one hour following the live broadcast through April 12, 2013.

About Geron

Geron is a biopharmaceutical company developing first-in-class therapies for
cancer, including its telomerase inhibitor, imetelstat, in clinical
development. For more information about Geron, visit


Anna Krassowska, Ph.D.
Investor and Media Relations



This announcement is distributed by Thomson Reuters on behalf of Thomson
Reuters clients.

The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and other
applicable laws; and
(ii) they are solely responsible for the content, accuracy and originality of
information contained therein.

Source: Geron Corp. via Thomson Reuters ONE
Sponsored Links
Sponsored Links